Cargando…

An examination of the Apo-1/Fas promoter Mva I polymorphism in Japanese patients with multiple sclerosis

BACKGROUND: The Apo-1/Fas (CD95) molecule is an apoptosis-signaling cell surface receptor belonging to the tumor necrosis factor (TNF) receptor family. Both Fas and Fas ligand (FasL) are expressed in activated mature T cells, and prolonged cell activation induces susceptibility to Fas-mediated apopt...

Descripción completa

Detalles Bibliográficos
Autores principales:	Niino, Masaaki, Kikuchi, Seiji, Fukazawa, Toshiyuki, Miyagishi, Ryuji, Yabe, Ichiro, Tashiro, Kunio
Formato:	Texto
Lenguaje:	English
Publicado:	BioMed Central 2002
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC122076/ https://www.ncbi.nlm.nih.gov/pubmed/12188927 http://dx.doi.org/10.1186/1471-2377-2-8

Ejemplares similares

Disease Exacerbation after the Cessation of Fingolimod Treatment in Japanese Patients with Multiple Sclerosis
por: Sato, Kazunori, et al.
Publicado: (2018)

Lack of KIR4.1 autoantibodies in Japanese patients with MS and NMO
por: Higuchi, Osamu, et al.
Publicado: (2016)

Latitude and HLA-DRB1*04:05 independently influence disease severity in Japanese multiple sclerosis: a cross-sectional study
por: Nakamura, Yuri, et al.
Publicado: (2016)

Structural equation modeling of factors contributing to quality of life in Japanese patients with multiple sclerosis
por: Kikuchi, Hiromi, et al.
Publicado: (2013)

Validation of the Brief International Cognitive Assessment for Multiple Sclerosis in Japan
por: Niino, Masaaki, et al.
Publicado: (2017)

Involvement of the CD95 (APO-1/Fas) receptor/ligand system in multiple sclerosis brain
Publicado: (1996)

Association of Smoking and Generalized Manifestations of Myasthenia Gravis
por: Miyazaki, Yusei, et al.
Publicado: (2021)

CD40 ligation induces Apo-1/Fas expression on human B lymphocytes and facilitates apoptosis through the Apo-1/Fas pathway
Publicado: (1995)

Levels of soluble Fas/APO-1 in patients with Behçet's disease.
por: Hamzaoui, K, et al.
Publicado: (1998)

No Evidence of HTLV‐1 Infection in Japanese Multiple Sclerosis Patients in Polymerase Chain Reaction
por: Watanabe, Toshiki, et al.
Publicado: (1989)

Fas–Fas Ligand: Checkpoint of T Cell Functions in Multiple Sclerosis
por: Volpe, Elisabetta, et al.
Publicado: (2016)

Signaling through the Death Receptor CD95 (APO-1/FAS)
por: Peter, Marcus E.
Publicado: (2001)

Prognostic impact of FAS/CD95/APO-1 in urothelial cancers: decreased expression of Fas is associated with disease progression
por: Yamana, K, et al.
Publicado: (2005)

Contribution of cortical lesions to cognitive impairment in Japanese patients with multiple sclerosis
por: Shinoda, Koji, et al.
Publicado: (2020)

Involvement of the CD95 (APO-1/Fas) receptor and ligand in liver damage
Publicado: (1995)

Elevated Concentrations of Soluble Fas and FasL in Multiple Sclerosis Patients with Antinuclear Antibodies
por: Sremec, Josip, et al.
Publicado: (2020)

Apoptotic signaling through CD95 (Fas/Apo-1) activates an acidic sphingomyelinase
Publicado: (1994)

Once‐daily glatiramer acetate decreases magnetic resonance imaging disease activity in Japanese patients with relapsing–remitting multiple sclerosis
por: Yamamura, Takashi, et al.
Publicado: (2017)

Percutaneous Vaccination as an Effective Method of Delivery of MVA and MVA-Vectored Vaccines
por: Meseda, Clement A., et al.
Publicado: (2016)

Multiple Sclerosis: Fas Signaling in Oligodendrocyte Cell Death
por: D'Souza, Sameer D., et al.
Publicado: (1996)

The 90 MVA transformer
Publicado: (1974)

Examination of Fas-Induced Apoptosis of Murine Thymocytes in Thymic Tissue Slices Reveals That Fas Is Dispensable for Negative Selection
por: Chu, Chang-Feng, et al.
Publicado: (2020)

Significance of serum-soluble CD95 (Fas/APO-1) on prognosis in renal cell cancer patients
por: Kimura, M, et al.
Publicado: (1999)

Selective cleavage of nuclear autoantigens during CD95 (Fas/APO-1)- mediated T cell apoptosis
Publicado: (1996)

APO-1/Fas gene: Structural and functional characteristics in systemic lupus erythematosus and other autoimmune diseases
por: Singh, Richa, et al.
Publicado: (2009)

Fibroblast growth factor 21 inhibits atherosclerosis in apoE−/− mice by ameliorating Fas-mediated apoptosis
por: Yan, Xinxin, et al.
Publicado: (2018)

72-Week Safety and Tolerability of Dimethyl Fumarate in Japanese Patients with Relapsing-remitting Multiple Sclerosis: Analysis of the Randomised, Double Blind, Placebo-Controlled, Phase III APEX Study and its Open-Label Extension
por: Ochi, Hirofumi, et al.
Publicado: (2018)

Apathy/depression, but not subjective fatigue, is related with cognitive dysfunction in patients with multiple sclerosis
por: Niino, Masaaki, et al.
Publicado: (2014)

p53 Activates the CD95 (APO-1/Fas) Gene in Response to DNA Damage by Anticancer Drugs
por: Müller, Martina, et al.
Publicado: (1998)

An MVA Approach to Missing $E_T$
por: Herwig, Theodor Christian
Publicado: (2013)

Ciliopathy in PCS (MVA) syndrome
por: Miyamoto, Tatsuo, et al.
Publicado: (2015)

Japanese local government management of compulsory hospitalization for patients with mental disorders and comorbid COVID-19
por: Naito, Nobushige, et al.
Publicado: (2021)

The extracellular domains of FasL and Fas are sufficient for the formation of supramolecular FasL-Fas clusters of high stability
por: Henkler, Frank, et al.
Publicado: (2005)

Absence of Bcl-2 and Fas/CD95/APO-1 predicts the response to immunotherapy in metastatic renal cell carcinoma
por: Maruyama, R, et al.
Publicado: (2006)

Mechanism of pyocyanin abolishment caused by mvaT mvaU double knockout in Pseudomonas aeruginosa PAO1
por: Dong, Limin, et al.
Publicado: (2019)

The Future of Smallpox Vaccination: is MVA the key?
por: Slifka, Mark K
Publicado: (2005)

DNA/MVA Vaccines for HIV/AIDS
por: Iyer, Smita S., et al.
Publicado: (2014)

Psychometric properties of the eating disorder examination-questionnaire in Japanese adolescents
por: Mitsui, Tomoyo, et al.
Publicado: (2017)

The Fas counterattack: Fas-mediated T cell killing by colon cancer cells expressing Fas ligand
Publicado: (1996)

Associations of serum soluble Fas and Fas ligand (FasL) with outcomes in systemic lupus erythematosus
por: Vincent, Fabien B, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_ovcjntflvqjo4vkhb9pg5d1435